Cargando…

Genome‐wide screening of abberant methylated drivers combined with relative risk loci in bladder cancer

BACKGROUND: To explore important methylation‐driven genes (MDGs) and risk loci to construct risk model for prognosis of bladder cancer (BCa). METHODS: We utilized TCGA‐Assembler package to download 450K methylation data and corresponding transcriptome profiles. MethylMix package was used for identif...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Chuanjie, Shen, Kangjie, Zheng, Yuxiao, Qi, Feng, Luo, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6970050/
https://www.ncbi.nlm.nih.gov/pubmed/31794632
http://dx.doi.org/10.1002/cam4.2665
_version_ 1783489438566842368
author Zhang, Chuanjie
Shen, Kangjie
Zheng, Yuxiao
Qi, Feng
Luo, Jun
author_facet Zhang, Chuanjie
Shen, Kangjie
Zheng, Yuxiao
Qi, Feng
Luo, Jun
author_sort Zhang, Chuanjie
collection PubMed
description BACKGROUND: To explore important methylation‐driven genes (MDGs) and risk loci to construct risk model for prognosis of bladder cancer (BCa). METHODS: We utilized TCGA‐Assembler package to download 450K methylation data and corresponding transcriptome profiles. MethylMix package was used for identifying methylation‐driven genes and functional analysis was mainly performed based on ConsensusPathDB database. Then, Cox regression method was utilized to find prognostic MDGs, and we selected 17 hub genes via stepwise regression and multivariate Cox models. Kruskal‐Wallis test was implemented for comparisons between risk with other clinical variables. Moreover, we constructed the risk model and validated it in http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE13507. Gene set enrichment analysis was performed using the levels of risk score as the phenotype. Additionally, we further screened out the relative methylation sites associated with the 17 hub genes. Cox regression and Survival analysis were conducted to find the specifically prognostic sites. RESULTS: Two hundred and twenty‐eight MDGs were chosen by ConsensusPathDB database. Results revealed that most conspicuous pathways were transcriptional mis‐regulation pathways in cancer and EMT. After Cox regression analysis, 17 hub epigenetic MDGs were identified. We calculated the risk score and found satisfactory predictive efficiency by ROC curve (AUC = 0.762). In the validation group from http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE13507, 17 hub genes remained higher predictive value with AUC = 0.723 and patients in high‐risk group. Meanwhile, Kruskal‐Wallis test revealed that higher risk score correlated with a higher level of TNM stage, tumor grade, and advanced pathological stages. Then, identified 38 risk methylated loci that highly associated with prognosis. Last, gene set enrichment analysis revealed that high‐risk level of MDGs may correlate with several important pathways, including MAPK signaling pathway and so on. CONCLUSION: Our study indicated several hub‐MDGs, calculated novel risk score and explored the prognostic value in BCa, which provided a promising approach to BCA prognosis assessment.
format Online
Article
Text
id pubmed-6970050
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-69700502020-01-27 Genome‐wide screening of abberant methylated drivers combined with relative risk loci in bladder cancer Zhang, Chuanjie Shen, Kangjie Zheng, Yuxiao Qi, Feng Luo, Jun Cancer Med Cancer Biology BACKGROUND: To explore important methylation‐driven genes (MDGs) and risk loci to construct risk model for prognosis of bladder cancer (BCa). METHODS: We utilized TCGA‐Assembler package to download 450K methylation data and corresponding transcriptome profiles. MethylMix package was used for identifying methylation‐driven genes and functional analysis was mainly performed based on ConsensusPathDB database. Then, Cox regression method was utilized to find prognostic MDGs, and we selected 17 hub genes via stepwise regression and multivariate Cox models. Kruskal‐Wallis test was implemented for comparisons between risk with other clinical variables. Moreover, we constructed the risk model and validated it in http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE13507. Gene set enrichment analysis was performed using the levels of risk score as the phenotype. Additionally, we further screened out the relative methylation sites associated with the 17 hub genes. Cox regression and Survival analysis were conducted to find the specifically prognostic sites. RESULTS: Two hundred and twenty‐eight MDGs were chosen by ConsensusPathDB database. Results revealed that most conspicuous pathways were transcriptional mis‐regulation pathways in cancer and EMT. After Cox regression analysis, 17 hub epigenetic MDGs were identified. We calculated the risk score and found satisfactory predictive efficiency by ROC curve (AUC = 0.762). In the validation group from http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE13507, 17 hub genes remained higher predictive value with AUC = 0.723 and patients in high‐risk group. Meanwhile, Kruskal‐Wallis test revealed that higher risk score correlated with a higher level of TNM stage, tumor grade, and advanced pathological stages. Then, identified 38 risk methylated loci that highly associated with prognosis. Last, gene set enrichment analysis revealed that high‐risk level of MDGs may correlate with several important pathways, including MAPK signaling pathway and so on. CONCLUSION: Our study indicated several hub‐MDGs, calculated novel risk score and explored the prognostic value in BCa, which provided a promising approach to BCA prognosis assessment. John Wiley and Sons Inc. 2019-12-03 /pmc/articles/PMC6970050/ /pubmed/31794632 http://dx.doi.org/10.1002/cam4.2665 Text en © 2019 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Cancer Biology
Zhang, Chuanjie
Shen, Kangjie
Zheng, Yuxiao
Qi, Feng
Luo, Jun
Genome‐wide screening of abberant methylated drivers combined with relative risk loci in bladder cancer
title Genome‐wide screening of abberant methylated drivers combined with relative risk loci in bladder cancer
title_full Genome‐wide screening of abberant methylated drivers combined with relative risk loci in bladder cancer
title_fullStr Genome‐wide screening of abberant methylated drivers combined with relative risk loci in bladder cancer
title_full_unstemmed Genome‐wide screening of abberant methylated drivers combined with relative risk loci in bladder cancer
title_short Genome‐wide screening of abberant methylated drivers combined with relative risk loci in bladder cancer
title_sort genome‐wide screening of abberant methylated drivers combined with relative risk loci in bladder cancer
topic Cancer Biology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6970050/
https://www.ncbi.nlm.nih.gov/pubmed/31794632
http://dx.doi.org/10.1002/cam4.2665
work_keys_str_mv AT zhangchuanjie genomewidescreeningofabberantmethylateddriverscombinedwithrelativerisklociinbladdercancer
AT shenkangjie genomewidescreeningofabberantmethylateddriverscombinedwithrelativerisklociinbladdercancer
AT zhengyuxiao genomewidescreeningofabberantmethylateddriverscombinedwithrelativerisklociinbladdercancer
AT qifeng genomewidescreeningofabberantmethylateddriverscombinedwithrelativerisklociinbladdercancer
AT luojun genomewidescreeningofabberantmethylateddriverscombinedwithrelativerisklociinbladdercancer